Research And Development Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Azelastine Fluticasone, Atc R01ad28 for the Period February 1St, 2024 - Jan...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Teriparatide, Atc H05aa02 for the Period February 1St, 2024 - January 31St,...

Open House Drug Discount Agreements Therapy Allergens, Atc V01aa05

Dynamic Purchasing System Qualification for Diathermy Equipment.

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Mesalazine, Atc A07ec02 for the Period February 1St, 2024 - January 31St, 2...

Conclusion of a Non-Exclusive Framework Agreement for Inspections in the Field of Road Construction in the Open House Procedure of the West Branch, Published in 2022

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Fampridine (Exclusively N3), Atc N07xx07 for the Period February 1St, 2024...

Open House Drug Discount Agreements Therapy Allergens, Atc V01aa03

Open House Drug Discount Agreements for Therapy Allergens with the Finished Drug Names Grazax(R) and Alk-Depot(R), Atc V01aa02

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Everolimus, Atc L04aa18 for the Period February 1St, 2024 - January 31St, 2...